Literature DB >> 24696606

Trefoil factors in inflammatory bowel disease.

Luise Aamann1, Else Marie Vestergaard1, Henning Grønbæk1.   

Abstract

Inflammatory bowel disease (IBD), which comprises ulcerative colitis and Crohn's disease, is characterized by inflammation of the gastrointestinal tract. The trefoil factors 1, 2, and 3 (TFF1-3) are a family of peptides that play important roles in the protection and repair of epithelial surfaces, including the gastrointestinal tract. TFFs may be involved in IBD pathogenesis and are a potential treatment option. In the present review, we describe the TFF family and their potential role in IBD by summarizing the current knowledge of their expression, possible function and pharmacological role in IBD.

Entities:  

Keywords:  Crohn’s disease; Inflammation; Inflammatory bowel disease; Trefoil factors; Ulcerative colitis

Mesh:

Substances:

Year:  2014        PMID: 24696606      PMCID: PMC3964394          DOI: 10.3748/wjg.v20.i12.3223

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  76 in total

Review 1.  Molecular medicine of TFF-peptides: from gut to brain.

Authors:  W Hoffmann; W Jagla; A Wiede
Journal:  Histol Histopathol       Date:  2001-01       Impact factor: 2.303

2.  Effect of trefoil factors on the viscoelastic properties of mucus gels.

Authors:  L Thim; F Madsen; S S Poulsen
Journal:  Eur J Clin Invest       Date:  2002-07       Impact factor: 4.686

Review 3.  Trefoil factors: initiators of mucosal healing.

Authors:  Douglas Taupin; Daniel K Podolsky
Journal:  Nat Rev Mol Cell Biol       Date:  2003-09       Impact factor: 94.444

4.  Trefoil peptide TFF2 treatment reduces VCAM-1 expression and leukocyte recruitment in experimental intestinal inflammation.

Authors:  Antonio Soriano-Izquierdo; Meritxell Gironella; Anna Massaguer; Felicity E B May; Antonio Salas; Miquel Sans; Richard Poulsom; Lars Thim; Josep M Piqué; Julián Panés
Journal:  J Leukoc Biol       Date:  2003-11-03       Impact factor: 4.962

5.  Tumour necrosis factor alpha and nuclear factor kappaB inhibit transcription of human TFF3 encoding a gastrointestinal healing peptide.

Authors:  M B Loncar; E-d Al-azzeh; P S M Sommer; M Marinovic; K Schmehl; M Kruschewski; N Blin; R Stohwasser; P Gött; T Kayademir
Journal:  Gut       Date:  2003-09       Impact factor: 23.059

6.  Development and evaluation of an ELISA for human trefoil factor 3.

Authors:  Else Marie Vestergaard; Steen Seier Poulsen; Henning Grønbaek; Rune Larsen; Anette Mertz Nielsen; Kirsten Ejskjaer; Jes Thorn Clausen; Lars Thim; Ebba Nexø
Journal:  Clin Chem       Date:  2002-10       Impact factor: 8.327

7.  Colonic expression of MUC2, MUC5AC, and TFF1 in inflammatory bowel disease in children.

Authors:  Ron Shaoul; Yoshio Okada; Ernest Cutz; Margaret A Marcon
Journal:  J Pediatr Gastroenterol Nutr       Date:  2004-05       Impact factor: 2.839

8.  Trefoil peptides as proangiogenic factors in vivo and in vitro: implication of cyclooxygenase-2 and EGF receptor signaling.

Authors:  Sylvie Rodrigues; Elisabeth Van Aken; Saskia Van Bocxlaer; Samir Attoub; Quang-Dé Nguyen; Erik Bruyneel; Bruce R Westley; Felicity E B May; Lars Thim; Marc Mareel; Christian Gespach; Shahin Emami
Journal:  FASEB J       Date:  2003-01       Impact factor: 5.191

9.  Chemotherapy- and radiotherapy-induced intestinal damage is regulated by intestinal trefoil factor.

Authors:  P L Beck; J F Wong; Y Li; S Swaminathan; R J Xavier; K L Devaney; Daniel K Podolsky
Journal:  Gastroenterology       Date:  2004-03       Impact factor: 22.682

10.  The trefoil factor 1 participates in gastrointestinal cell differentiation by delaying G1-S phase transition and reducing apoptosis.

Authors:  Carine Bossenmeyer-Pourié; Rama Kannan; Stéphane Ribieras; Corinne Wendling; Isabelle Stoll; Lars Thim; Catherine Tomasetto; Marie-Christine Rio
Journal:  J Cell Biol       Date:  2002-05-28       Impact factor: 10.539

View more
  40 in total

1.  Integrated omics profiling of dextran sodium sulfate-induced colitic mice supplemented with Wolfberry (Lycium barbarum).

Authors:  Wanping Aw; Huijuan Jia; Weida Lyu; Shinji Fukuda; Masaru Tomita; Lila Otani; Hisanori Kato
Journal:  NPJ Sci Food       Date:  2020-03-31

2.  Trefoil factor 3 mediation of oncogenicity and chemoresistance in hepatocellular carcinoma is AKT-BCL-2 dependent.

Authors:  Ming-Liang You; Yi-Jun Chen; Qing-Yun Chong; Ming-Ming Wu; Vijay Pandey; Ru-Mei Chen; Liang Liu; Lan Ma; Zheng-Sheng Wu; Tao Zhu; Peter E Lobie
Journal:  Oncotarget       Date:  2017-06-13

Review 3.  The intestinal microbiome, barrier function, and immune system in inflammatory bowel disease: a tripartite pathophysiological circuit with implications for new therapeutic directions.

Authors:  Stephen M Vindigni; Timothy L Zisman; David L Suskind; Christopher J Damman
Journal:  Therap Adv Gastroenterol       Date:  2016-04-19       Impact factor: 4.409

Review 4.  Structure, Function, and Therapeutic Potential of the Trefoil Factor Family in the Gastrointestinal Tract.

Authors:  Nayara Braga Emidio; Stuart M Brierley; Christina I Schroeder; Markus Muttenthaler
Journal:  ACS Pharmacol Transl Sci       Date:  2020-06-09

5.  Localization of trefoil factor family peptide 3 (TFF3) in epithelial tissues originating from the three germ layers of developing mouse embryo.

Authors:  Nikola Bijelić; Tatjana Belovari; Maja Tolušić Levak; Mirela Baus Lončar
Journal:  Bosn J Basic Med Sci       Date:  2017-08-20       Impact factor: 3.363

6.  Trefoil factor-3 is not a useful marker of mucosal healing in Crohn's disease treated with anti-TNF-α antibodies.

Authors:  Piotr Eder; Kamila Stawczyk-Eder; Katarzyna Korybalska; Natasza Czepulis; Joanna Luczak; Liliana Lykowska-Szuber; Iwona Krela-Kazmierczak; Krzysztof Linke; Janusz Witowski
Journal:  World J Gastroenterol       Date:  2017-01-07       Impact factor: 5.742

7.  Hypoxic Environment Promotes Barrier Formation in Human Intestinal Epithelial Cells through Regulation of MicroRNA 320a Expression.

Authors:  Megan L Stanifer; Steeve Boulant; Stephanie Muenchau; Rosalie Deutsch; Ines J de Castro; Thomas Hielscher; Nora Heber; Beate Niesler; Marina Lusic
Journal:  Mol Cell Biol       Date:  2019-06-27       Impact factor: 4.272

8.  Proteolytic effects of gingipains on trefoil factor family peptides.

Authors:  Ponlatham Chaiyarit; Janthima Jaresitthikunchai; Narumon Phaonakrop; Sittiruk Roytrakul; Barbara Potempa; Jan Potempa
Journal:  Clin Oral Investig       Date:  2017-07-19       Impact factor: 3.573

9.  Combining an epithelial repair factor and anti-fibrotic with a corticosteroid offers optimal treatment for allergic airways disease.

Authors:  K P Patel; A S Giraud; C S Samuel; S G Royce
Journal:  Br J Pharmacol       Date:  2016-05-05       Impact factor: 8.739

Review 10.  Resolution of Inflammation and Gut Repair in IBD: Translational Steps Towards Complete Mucosal Healing.

Authors:  Gwo-Tzer Ho; Jennifer A Cartwright; Emily J Thompson; Calum C Bain; Adriano G Rossi
Journal:  Inflamm Bowel Dis       Date:  2020-07-17       Impact factor: 5.325

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.